Table 2

Baseline characteristics of 1239 patients presenting with acute myocardial infarction and ST elevation, stratified for Q wave development

Q wave infarction (n=979) Non-Q wave infarction (n=248) p Value
Age (years)62.0 (53 to 71)61.0 (52.5 to 69.5)NS
Male sex708 (72.3)182 (73.4)NS
Racial group
 African28 (2.9)12 (4.8)
 Asian258 (26.4)59 (23.8)
 White693 (70.8)177 (71.4)NS
Smoking502 (52.6)148 (60.2)0.03
Hypertension303 (31.3)79 (32.0)NS
Diabetes190 (19.5)56 (22.6)NS
Previous treatment with:
 Aspirin84 (9.1)36 (15.5)0.005
 β Blocker90 (9.8)27 (11.7)NS
Emergency treatment with:
 Aspirin865 (89.6)230 (93.5)0.07
 Thrombolysis771 (79.1)204 (82.3)NS
Pain duration < 120 min473 (51.7)125 (52.1)NS
Admission biochemistry (mmol/l)
 Glucose9.0 (5.9 to 12.1)8.5 (5.8 to 11.2)NS
 Potassium4.0 (3.7 to 4.3)4.0 (3.7 to 4.3)NS
Mortality
 30 Days149 (15.2)11 (4.4)< 0.001
 6 Months176 (18.0)14 (5.6)< 0.001
  • Q wave data unavailable in 12 patients. Data are numbers (percentages), except for age, glucose, and potassium, which are median values (interquartile range).